Errin Samuëlsz

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Acute Lymphoblastic Leukemia

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel H Ahn, Afsaneh Barzi, Maya Ridinger, Errin Samuëlsz, Ramanand A Subramanian, Peter J P Croucher, Tod Smeal, Fairooz F Kabbinavar, Heinz-Josef Lenz
Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Phase Ib Clinical Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Daniel H Ahn, Afsaneh Barzi, Maya Ridinger, Errin Samuëlsz, Ramanand A Subramanian, Peter J P Croucher, Tod Smeal, Fairooz F Kabbinavar, Heinz-Josef Lenz
Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Phase Ib Clinical Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Daniel H Ahn, Afsaneh Barzi, Maya Ridinger, Errin Samuëlsz, Ramanand A Subramanian, Peter J P Croucher, Tod Smeal, Fairooz F Kabbinavar, Heinz-Josef Lenz
Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Phase Ib Clinical Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Daniel H Ahn, Afsaneh Barzi, Maya Ridinger, Errin Samuëlsz, Ramanand A Subramanian, Peter J P Croucher, Tod Smeal, Fairooz F Kabbinavar, Heinz-Josef Lenz
Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-line Treatment of KRAS-mutant Metastatic Colorectal Cancer: A Phase 1b Clinical Study. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Daniel H Ahn, Afsaneh Barzi, Maya Ridinger, Errin Samuëlsz, Ramanand A Subramanian, Peter J P Croucher, Tod Smeal, Fairooz F Kabbinavar, Heinz-Josef Lenz
Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Phase Ib Clinical Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Amer M Zeidan, Maya Ridinger, Tara L Lin, Pamela S Becker, Gary J Schiller, Prapti A Patel, Alexander I Spira, Michaela L Tsai, Errin Samuëlsz, Sandra L Silberman, Mark Erlander, Eunice S Wang
A Phase Ib Study of Onvansertib, a Novel Oral PLK1 Inhibitor, in Combination Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (23) (2020)